ATLANTA, GA - According to an SEC filing, ADial Pharmaceuticals, L.L.C., developer of medications to treat addictions, completed a $4.1 million offering.

The company was founded by Prof. Bankole Johnson, who serves as president and chairman. (more…)

The University of Florida has been ranked among the nation’s leaders at transferring world-class research to commercial partners capable of turning these discoveries into commercial products that are impacting the world. Often times the commercial partner is a company created solely for this purpose. These companies require tremendous resources both in terms of business and scientific talent as well as capital.

Our Celebration of Innovation is a unique opportunity to see start-up companies in the areas of life sciences, medical devices, and information technology that are commercializing the latest in cutting-edge technologies generated as a result of $678 million in research conducted at UF. Those interested in licensing, commercializing, investing or otherwise becoming involved with getting new discoveries into the marketplace will want to mark their calendars to attend the fifth annual Innovation Showcase.

http://conferences.dce.ufl.edu/innovationshowcase/

ATLANTA, GA - Georgia Bio welcomes you to share your expertise and insight at the 2011 Georgia Life Sciences Summit on September 28, 2011.  This year’s theme is “Bioscience at a Crossroads” and will address what lies ahead for biotech in an environment that is challenged by healthcare reform, economic crisis and societal challenges. We invite you to submit an idea for a panel, a case study, a fireside or roundtable discussion, or other interesting or interactive session format.

(more…)

RESEARCH TRIANGLE PARK, NC – Bioptigen Inc., a company that has developed in vivo optical imaging systems that enables real-time, noninvasive imaging of internal tissue microstructure, has raised $1.5 million from a single investor, according to a regulatory filing. (more…)

RESEARCH TRIANGLE PARK, NC – Aerie Pharmaceuticals, Inc, a biotechnology company focused on the discovery and development of medical innovations in ophthalmology, has closed a $30 million Series B financing. Clarus Ventures and Sofinnova Ventures co-led the round, with participation from Osage University Partners, and existing investors Alta Partners and TPG Biotech. (more…)

RESEARCH TRIANGLE, NC – Liquidia Technologies, a nanotechnology firm, has received a $10 million investment from the Bill & Melinda Gates Foundation. The financing follows Liquidia’s partnership in a global campaign against malaria, one of the Gates’ Foundation’s targets. (more…)